MedPath

Effectiveness of Wound Drains for the Prevention Of Surgical sITe infectION

Not Applicable
Completed
Conditions
Gynecologic Cancer
Surgical Site Infection
Wound Drain
Interventions
Procedure: Surgical drain
Registration Number
NCT05179122
Lead Sponsor
National and Kapodistrian University of Athens
Brief Summary

The aim of the present randomized trial is to assess the efficacy of wound drains in terms of reducing the rates of surgical site infection in obese patients with gynecological cancer.

Detailed Description

Many prophylactic methods have been suggested for the treatment of surgical wound infections, including the prolonged administration of antibiotics as well as the use of subcutaneous tissue drainage, the use of which has been shown to be particularly effective in overweight patients. While its importance seems to be moderate in obese patients as well as those that suffer from malignant disease, to date, it remains unknown if wound drains may help reduce the rates of surgical site infection in obese patients that suffer from cancer. In the field of gynecological oncology data are limited to anachronistic studies whose methodological value is limited; hence, guidelines are primarily based in data of high risk of bias as to date, the value of subcutaneous tissue drainage in obese women undergoing surgery for gynecological cancer has not been documented in a large randomized study.

Considering the significant impact of surgical site infection on the interval to adjuvant therapy (as patients with infectious diseases cannot receive chemotherapy or radiotherapy), it becomes evident that every effort has to be made in order to help reduce the rates of SSI to help maintain acceptable intervals that will ensure appropriate care of patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria

This prospective randomized study will include obese (BMI> 35) patients who will undergo primary surgery for ovarian or endometrial cancer

Exclusion Criteria

Immunodeficient patients (systemic disease including HIV infection, systemic lupus erythematosus etc) Patients with hematologic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Surgical drainSurgical drainIn this arm participants a surgical drain (Redon type) will be inserted above the abdominal fascia prior to suture of the subcutaneous tissue and of the skin
Primary Outcome Measures
NameTimeMethod
Prevalence of surgical site infectionWithin 30 days

Surgical site infection will be defined as redness, swelling, pain, bleeding, or any discharge from the surgical site

Risk of surgical debridement of surgical site infectionWithin 30 days

Rates of surgical intervention to treat surgical site infection will be recorded

Secondary Outcome Measures
NameTimeMethod
Risk of wound dehiscenceWithin 30 days

Rates of wound dehiscence (skin and/or fascia dehiscence) following surgical site infection or spontaneously (non-related to surgical site infection) will be recorded

Length and depth of wound dehiscenceWithin 30 days

In case of wound dehiscence the length and depth will be measured in cm

Risk of seroma formationWithin 30 days

Rates of formation of seroma (defined as the collection of non-purulent fluid) in the surgical wound will be recorded.

Duration of antibiotic therapy directed against surgical site infectionWithin 30 days

The duration of post-operative use of antibiotics will be recorded in days

Re-admission ratesWithin 30 days

Re-admission rates within 30 days will be reported

Interval to adjuvant therapyWithin 30 days

The interval to adjuvant therapy (chemo- and/or radiotherapy) will be recorded in days

Risk and duration of fever related to surgical site infectionWithin 30 days

Rates of fever related to surgical site infection and following exclusion of other causes will be reported in degrees of Celsius

Duration of hospitalizationWithin 30 days

Duration of hospitalization will be recorded in days

Trial Locations

Locations (1)

Alexandra Hospital

🇬🇷

Athens, Attika, Greece

© Copyright 2025. All Rights Reserved by MedPath